Market Chatter: Eli Lilly CEO Plans Larger Deals to Target New Disease Areas

MT newswire2026/09/28 18:13

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

02:13 PM EDT, 09/28/2026 (MT Newswires) -- Eli Lilly (LLY) plans to pursue larger pharmaceutical deals as it looks to expand into new therapeutic areas, Bloomberg News reported Monday, citing an interview with CEO David Ricks on the sidelines of a diabetes conference in Milan. Ricks cited infectious disease, women's health, and psychiatric conditions as possible areas of opportunity in a broadening search for pharmaceutical deals, the report said. Lilly didn't immediately reply to a request for comment from MT Newswires. (Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.) Price: 1186.63, Change: +3.16, Percent Change: +0.27

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

U.S. Treasury Secretary Janet Yellen defended the rise in U.S. Treasury yields, stating that this increase is a global phenomenon rather than unique to the United States, and does not warrant excessive concern. She partially attributed inflationary pressures to higher oil prices caused by the Iran conflict, and expects the energy shock to subside as hostilities ease. Yellen refuted the notion of an AI bubble, arguing that investments by major tech companies are grounded in solid business logic.

华尔街见闻•2026/10/04 03:06